Aussie Regulator Streamlines Submission of AE Reports

International Pharmaceutical Regulatory Monitor
A A
Drugmakers can now submit adverse event reports to the Therapeutic Goods Administration via email using the international E2B standard alone — a move aimed at reducing manual data entry and duplicate handling of information.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00